Related references
Note: Only part of the references are listed.Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase IIb trial
Matthieu Mahevas et al.
HAEMATOLOGICA (2021)
Population-based studies in systemic lupus erythematosus: immune thrombocytopenic purpura or 'blood-dominant' lupus?
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study
Fang-Xiao Zhu et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Rituximab or cyclosporin in refractory immune thrombocytopenia secondary to connective tissue diseases: a real-world observational retrospective study
Fangfang Sun et al.
CLINICAL RHEUMATOLOGY (2020)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Treatment of primary and secondary immune thrombocytopenia
Ruba Kado et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
Stephanie L. Savelli et al.
FRONTIERS IN IMMUNOLOGY (2019)
Autoimmune haemolytic anaemia and thrombocytopaenia in a single-centre cohort of patients with systemic lupus erythematosus from Turkey: clinical associations and effect on disease damage and survival
B. Artim-Esen et al.
LUPUS (2019)
Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux
Samuel Deshayes et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Thrombocytopenia as a Prognostic Marker for Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis
Zhixian Chen et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)
Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults
Alexandra Serris et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Splenectomy in systemic lupus erythematosus and autoimmune hematologic disease: a comparative analysis
Nahim Barron et al.
CLINICAL RHEUMATOLOGY (2018)
Retrospective analysis of the risk of hemorrhage associated with moderate and severe thrombocytopenia of 173 patients with systemic lupus erythematosus
Jie Li et al.
MEDICINE (2018)
Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice
Fabian Depre et al.
PLOS ONE (2018)
Thrombopoietin receptor agonist, splenectomy and intravenous immunoglobulin for immune thrombocytopaenia with systemic lupus erythematosus
Hideaki Sofue et al.
RHEUMATOLOGY (2018)
Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists
Zelie Guitton et al.
RHEUMATOLOGY (2018)
Severe thrombocytopenia in connective tissue diseases: a single-center review of 131 cases
Wei Zhang et al.
CLINICAL RHEUMATOLOGY (2018)
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus
Jean-Francois Kleinmann et al.
AUTOIMMUNITY REVIEWS (2017)
The diagnosis and management of the haematologic manifestations of lupus
Alba Velo-Garcia et al.
JOURNAL OF AUTOIMMUNITY (2016)
Thrombocytopenia in Systemic Lupus Erythematosus Clinical Manifestations, Treatment, and Prognosis in 230 Patients
Jin-Hee Jung et al.
MEDICINE (2016)
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus
Ozan Unlu et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2016)
Treatment Algorithms in Systemic Lupus Erythematosus
Chayawee Muangchan et al.
ARTHRITIS CARE & RESEARCH (2015)
Bleeding complications in immune thrombocytopenia
Donald M. Arnold
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2015)
Haematological manifestations of lupus
Anum Fayyaz et al.
LUPUS SCIENCE & MEDICINE (2015)
Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies
Mehdi Khellaf et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Benefits and risks of splenectomy
Elroy P. Weledji
INTERNATIONAL JOURNAL OF SURGERY (2014)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia
Patrick F. Fogarty et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Splenectomy for thrombocytopenia associated with systemic lupus erythematosus in 11 Chinese patients
Ruixia Li et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Danazol in the Treatment of Systemic Lupus Erythematosus: A Qualitative Systematic Review
Pagalavan Letchumanan et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review
Cc Mok
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2007)
Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment
S Giannouli et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus
L Quartuccio et al.
LUPUS (2006)
Lupus thrombocytopenia: clinical implications and prognostic significance
PD Ziakas et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus
YN You et al.
ANNALS OF SURGERY (2004)
Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil
S Vasoo et al.
LUPUS (2003)
Share Paper
